acetylshikonin has been researched along with Liver Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, M; Li, J; Li, S; M Almutairi, M | 1 |
Cho, IR; Choi, YW; Chung, YH; Jhun, BH; Kaewpiboon, C; Kaowinn, S; Koh, SS; Lee, K; Malilas, W; Moon, J | 1 |
Chen, J; Chen, XJ; Ma, XY; Shao, ZJ; Wan, LH; Wu, YY; Zhou, LM; Zhu, L | 1 |
3 other study(ies) available for acetylshikonin and Liver Neoplasms
Article | Year |
---|---|
Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Biomarkers, Tumor; Carcinoma, Hepatocellular; Caspases; Cell Line, Tumor; Disease Models, Animal; DNA Damage; Drug Synergism; Drugs, Chinese Herbal; Hep G2 Cells; Humans; Immunohistochemistry; Liver Neoplasms; Mice; Models, Biological; Reactive Oxygen Species; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand | 2019 |
Acetylshikonin induces apoptosis of hepatitis B virus X protein-expressing human hepatocellular carcinoma cells via endoplasmic reticulum stress.
Topics: Anthraquinones; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Endoplasmic Reticulum Stress; Humans; Liver Neoplasms; MAP Kinase Kinase 4; Nuclear Receptor Subfamily 4, Group A, Member 1; RNA, Small Interfering; Trans-Activators; Up-Regulation; Viral Regulatory and Accessory Proteins | 2014 |
The anti-proliferation effect of Aikete injection on hepatocellular carcinoma in vitro and in vivo.
Topics: Animals; Anthraquinones; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Genes, bcl-2; Humans; Injections; Liver Neoplasms; Male; Mice; Naphthoquinones | 2011 |